Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 21, 2026
TickeronGET DAILY SIGNALS
EFA vs SCHF: Weighing Two Leading Foreign Large-Blend ETFs

EFA vs SCHF: Weighing Two Leading Foreign Large-Blend ETFs

Key Takeaways

  • Both EFA and SCHF are passive, market-cap-weighted "foreign large blend" funds, but they track different indexes with meaningfully different country and sector exposures.
  • SCHF tracks the FTSE Developed ex-US Index, which includes Canada and South Korea; EFA tracks the MSCI EAFE Index, which excludes both of those markets.
  • SCHF is dramatically cheaper at roughly a 0.06% expense ratio versus EFA's 0.32%, and it holds roughly twice as many stocks (about 1,400+ versus about 700).
  • SCHF carries a larger allocation to information technology, driven by South Korean semiconductor leaders, while EFA skews slightly more toward financials and health care.
  • Both funds share overlapping heavyweights such as ASML, HSBC, Roche, Novartis, and Shell, so their core European and Japanese exposure is similar.
  • Tickeron AI Verdict: SCHF — its lower cost, broader diversification, and additional technology exposure give it a structural edge for long-term investors.

Why Compare These Two International ETFs?

Investors looking for developed-market equity exposure outside the United States often weigh EFA and SCHF, two of the largest and most liquid international ETFs. Although both sit in the same Morningstar category of foreign large blend, they are not identical. EFA has served as a portfolio anchor for decades, while SCHF has emerged as a lower-cost, more diversified alternative. Small differences in index construction can shift country, sector, and performance profiles over time, which is why I find this comparison worthwhile in the current environment.

Breaking Down EFA

The iShares MSCI EAFE ETF tracks the MSCI EAFE Index, a free-float-adjusted, market-capitalization-weighted benchmark of large- and mid-cap equities across developed markets in Europe, Australasia, and the Far East, excluding the United States and Canada. The fund is passively managed and typically holds roughly 680 to 720 positions, with assets under management around $77 billion. Its top holdings include ASML Holding, HSBC Holdings, Roche Holding, Novartis, Shell, Nestlé, AstraZeneca, Siemens, Mitsubishi UFJ Financial Group, and BHP Group, with the top 10 names representing only about 14% of assets. By sector, financials (roughly 25%) and industrials (roughly 19%) lead, followed by information technology (about 11%), health care (about 10%), and consumer discretionary (about 7.5%). The fund carries a net expense ratio of 0.32% and has operated since 2001.

Understanding SCHF

The Schwab International Equity ETF tracks the FTSE Developed ex-US Index, a market-cap-weighted benchmark of large- and mid-cap companies in developed markets outside the United States. It is passively managed and holds roughly 1,400 to 1,500 stocks—about twice as many as EFA—with AUM of approximately $60 billion and a very low expense ratio of about 0.06%. SCHF's top holdings include Samsung Electronics, ASML Holding, SK Hynix, Roche Holding, HSBC Holdings, Royal Bank of Canada, Shell, Novartis, AstraZeneca, and Nestlé. The presence of Samsung, SK Hynix, and Royal Bank of Canada reflects a key difference: the FTSE index treats South Korea as developed and includes Canada, while MSCI EAFE does not. By sector, SCHF holds roughly 24% in financials, 19% in industrials, and a higher information technology weighting of about 14%, with health care near 7.5%. Its top 10 names account for roughly 13% of assets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Themes Shaping Both Funds

Both ETFs are influenced by the same macro forces: monetary policy divergence among the European Central Bank, Bank of Japan, and U.S. Federal Reserve; currency movements in the euro, yen, and pound; and the earnings path of large European and Japanese banks and exporters. Financials and industrials remain sensitive to interest rate expectations and global trade. A notable recent theme has been the outperformance of semiconductor and artificial-intelligence-linked names, which benefits SCHF more through its South Korean exposure to Samsung Electronics and SK Hynix. EFA captures less of that momentum. Geopolitical and regulatory developments in Europe, along with energy price volatility, also influence positioning. Because neither fund hedges currency, U.S. dollar movements remain a shared risk factor. From what I see, this currency exposure is worth monitoring closely.

Performance, Costs, and Positioning

Over recent cycles, the two funds have moved closely together during broad risk-on and risk-off periods due to their shared European and Japanese core. SCHF's higher information technology allocation and South Korean memory-chip exposure have allowed it to capture more upside in semiconductor-led rallies, while EFA's larger financial and health care weightings have made it slightly more defensive in risk-averse periods. On cost, SCHF's 0.06% expense ratio versus EFA's 0.32% represents a persistent advantage that compounds over long periods. Volatility differences have been modest, but SCHF's broader portfolio and Canadian exposure provide marginally greater diversification. EFA offers deeper trading liquidity and a longer track record, which some investors value. One thing that stands out is how these structural edges play out over time.

Using AI Tools in My Research

In my own analysis of international ETFs, I regularly turn to Tickeron’s AI Screener to filter holdings by sector, market cap, and technical signals. It provides a data-driven way to compare relative positioning across the same criteria, helping refine the universe of options without manual effort. This approach has become a standard part of how I evaluate funds like these before making allocation decisions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EFA, SCHF

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


EFA sees MACD Histogram crosses below signal line

EFA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFA as a result. In 63 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

EFA moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

The Aroon Indicator for EFA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFA advanced for three days, in 260 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

EFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Spotify Technology SA (NYSE:SPOT), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Nokia Corp (NYSE:NOK), Nebius Group N.V. (NASDAQ:NBIS).

Industry description

The investment seeks to track the investment results of the MSCI EAFE Index composed of large- and mid-capitalization developed market equities, excluding the U.S. and Canada. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted, market capitalization-weighted index designed to measure large- and mid-capitalization equity market performance of developed markets outside of the U.S. and Canada.

Market Cap

The average market capitalization across the iShares MSCI EAFE ETF (EFA) ETF is 47.28B. The market cap for tickers in the group ranges from 439.99M to 123.97B. SPOT holds the highest valuation in this group at 123.97B. The lowest valued company is HKD at 439.99M.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was -8%. For the same ETF, the average monthly price growth was -8%, and the average quarterly price growth was -6%. CHKP experienced the highest price growth at 5%, while USD experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was 59%. For the same stocks of the ETF, the average monthly volume growth was 37% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 54
Price Growth Rating: 55
SMR Rating: 60
Profit Risk Rating: 62
Seasonality Score: 7 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.